Summary: Researchers reveal which specific brain cells and circuits are most vulnerable in Alzheimer’s disease and identify cellular factors that may support resilience to cognitive decline.
By comparing gene expression in more than 1.3 million single cells across six brain regions, the study highlights a protective role for Reelin-producing neurons and links choline metabolism in astrocytes to preserved cognition. These insights point to new molecular targets for therapies aimed at maintaining memory and cognition even when Alzheimer’s pathology is present.
Key Facts:
- Neurons that produce or respond to Reelin are associated with cognitive resilience and are depleted in Alzheimer’s-affected regions.
- Astrocyte programs involving choline metabolism, polyamine biosynthesis, and antioxidant activity correlate with preserved cognition despite high pathology.
- Single-cell gene expression analysis of over 1.3 million cells across multiple brain regions reveals cell-type- and region-specific vulnerability and resilience signatures.
Source: Picower Institute at MIT
An MIT study published in Nature provides a large-scale single-cell view of how aging human brains respond to Alzheimer’s pathology, identifying vulnerable neuronal populations and cellular programs linked to resilience.
To pinpoint potential intervention targets for sustaining memory and cognition, the authors compared single-cell gene expression across multiple brain regions from people with and without Alzheimer’s disease and validated key findings with laboratory experiments.
Although all brain cells share the same DNA, they differ in identity and behavior because of how their genes are expressed. The researchers measured gene expression in more than 1.3 million cells spanning over 70 cell types from six brain regions of 48 donors—26 with a clinical diagnosis of Alzheimer’s and 22 without—creating a broad, high-resolution map of region- and cell-type-specific responses to disease pathology.
The dataset provides a detailed account of how gene expression and cell-type composition change with Alzheimer’s pathology and how those changes relate to each donor’s cognitive performance before death.
“Specific brain regions are particularly vulnerable in Alzheimer’s, and we need to understand which cell types and circuits are affected,” said co-senior author Li-Huei Tsai, Picower Professor of Neuroscience and director of the Picower Institute and the Aging Brain Initiative at MIT. “The brain includes many non-neuronal cell types, and their regional responses are just beginning to come into focus.”
Co-senior author Manolis Kellis, professor of computer science and head of MIT’s Computational Biology Group, compared single-cell RNA profiling to an advanced microscope that reveals disease responses gene by gene and cell by cell—far beyond the structural hallmarks Alois Alzheimer observed a century ago.
The team analyzed the prefrontal cortex, entorhinal cortex, hippocampus, anterior thalamus, angular gyrus, and midtemporal cortex. Brain samples originated from the Religious Orders Study and the Rush Memory and Aging Project at Rush University.
Neural vulnerability and Reelin
Early amyloid accumulation and neuron loss often appear in memory centers such as the hippocampus and entorhinal cortex. The analysis identified one excitatory neuron subtype in the hippocampus and four in the entorhinal cortex that were markedly depleted in donors with Alzheimer’s. Loss of these neurons correlated with poorer cognitive test results.
Many of these vulnerable neurons formed a connected circuit and either produced Reelin or were affected by Reelin signaling. This convergence of circuit-level connectivity and a shared molecular pathway points to Reelin as a factor of interest: its presence appears linked to cognitive preservation, while loss of Reelin-producing neurons associates with decline.
Reelin has attracted attention recently after a rare case in which an individual with a hyperactive Reelin mutation remained cognitively healthy despite a strong genetic predisposition to early-onset Alzheimer’s. While the mechanism remains unclear, the new findings reinforce Reelin’s potential protective role and show that Reelin-positive neurons are reduced in affected regions in both human samples and Alzheimer’s model mice.
The study also tied previously identified vulnerable inhibitory neuron subtypes to Reelin signaling, strengthening the case that this pathway influences neuronal vulnerability.
Resilience linked to choline metabolism in astrocytes
To uncover factors associated with preserved cognition despite pathology, the researchers defined cognitive resilience as better-than-expected cognitive performance given the observed level of brain pathology. Across several regions, astrocytes from resilient individuals showed elevated expression of genes involved in antioxidant defenses, choline metabolism, and polyamine biosynthesis.
These results echo prior work by Tsai and colleagues showing that dietary choline can support astrocyte lipid regulation in the context of APOE4 risk. The antioxidant-associated program also highlighted molecules such as spermidine—found in some supplements—as candidates for further study, although causal effects remain to be established.
Importantly, direct examination of brain tissue from cognitively resilient donors confirmed increased expression of the astrocyte genes predicted by the single-cell analysis, strengthening the link between these programs and preserved cognition.
New analysis method and public dataset
To manage the complexity of the single-cell data, the team developed a scalable method that identifies coordinated groups of genes (“gene modules”). By focusing on modules—sets of functionally linked genes that change together—the approach detects robust, interpretable shifts in cellular programs across regions, cell types, and disease states.
Kellis compared the approach to recognizing coordinated movements (walking, running, dancing) instead of every possible contortion: modules reveal the biologically meaningful programs that cells deploy.
The authors have made the dataset and analysis tools available to the research community, expecting that many additional discoveries will emerge as investigators explore the resource.
Next steps include mapping regulatory control of the identified modules to discover genetic variants, regulatory factors, and potential intervention points that could reverse or mitigate disease-related circuit changes across regions, cell types, and disease stages.
Additional authors include Ziting Xia, Jose Davila Velderrain, Ayesha P. Ng, Xueqiao Jiang, Ghada Abdelhady, Kyriaki Galani, Julio Mantero, Neil Band, Benjamin T. James, Sudhagar Babu, Fabiola Galiana-Melendez, Kate Louderback, Dmitry Prokopenko, Rudolph E. Tanzi, and David A. Bennett.
Funding: The research was supported by the National Institutes of Health, the Picower Institute for Learning and Memory, the JPB Foundation, the Cure Alzheimer’s Fund, the Robert A. and Renee E. Belfer Family Foundation, Eduardo Eurnekian, and Joseph DiSabato.
About this Alzheimer’s disease research news
Author: David Orenstein
Source: Picower Institute at MIT
Contact: David Orenstein – Picower Institute at MIT
Image: The image is credited to Neuroscience News
Original Research: “Single-cell multiregion dissection of Alzheimer’s disease” by Li-Huei Tsai et al., published in Nature (open access).
Abstract
Single-cell multiregion dissection of Alzheimer’s disease
Alzheimer’s disease is the leading cause of dementia worldwide, yet the cellular pathways that drive its progression across brain regions are not well understood. This study presents a single-cell transcriptomic atlas of six brain regions in the aged human brain, covering 1.3 million cells from 283 post-mortem samples across 48 individuals with and without Alzheimer’s disease.
The work identifies 76 cell types, including region-specific astrocyte and excitatory neuron subtypes and a thalamus-specific inhibitory interneuron population. Vulnerable excitatory and inhibitory neuron populations depleted in Alzheimer’s were characterized, with evidence implicating the Reelin signaling pathway in their vulnerability.
Using a scalable gene-module discovery method, the study maps cell-type- and region-specific transcriptomic changes linked to pathology and uncovers an astrocyte program—centered on choline metabolism and polyamine biosynthesis—associated with cognitive resilience. Overall, the study builds a regional atlas of the aging human brain and provides insights into cellular vulnerability, response, and resilience to Alzheimer’s disease pathology.